RVNC

Revance Therapeutics, Inc.

Delisted

RVNC was delisted on the 5th of February, 2025.

81 hedge funds and large institutions have $540M invested in Revance Therapeutics, Inc. in 2016 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 31 increasing their positions, 20 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
81
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$364K
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
51
$391K
52
$374K
53
$323K
54
$311K
55
$276K
56
$275K
57
$243K
58
$225K
59
$222K
60
$222K
61
$174K
62
$168K
63
$167K
64
$145K
65
$116K
66
$113K
67
$53K
68
$35K
69
$30K
70
$23.7K
71
$22K
72
$17K
73
$16K
74
$12K
75
$8K